Abstract
RECENT REPORTS 1 indicate that the administration of measles vaccine for active immunization of susceptible children has not yet reached desirable levels, and that 20 million children under the age of 10, living in the United States, are unprotected. Several factors probably account for this, including lack of information, cost of the procedure, and the possibility or fear of reaction. The latter has been specifically related to egg-allergic children, of whom there are conservatively estimated to be over 50,000 among the allergic pediatric population of the United States. Since reactions to virus vaccines have occurred in the past among eggallergic children, 2-4 the manufacturers of virus vaccines have routinely cautioned that such children should not receive live, attenuated virus vaccine immunizations. In a previous study, 5 we administered live, attenuated measles virus vaccine to 11 children from 1 to 6 1/2 years of age, each of whom repeatedly demonstrated severe
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
